Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 69 | 2025 | 3213 | 5.540 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 12 | 2021 | 550 | 1.590 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 8 | 2024 | 253 | 1.450 |
Why?
|
Fatigue | 11 | 2023 | 1549 | 1.200 |
Why?
|
Quality of Life | 18 | 2023 | 13462 | 1.110 |
Why?
|
Cognition Disorders | 11 | 2020 | 3967 | 0.930 |
Why?
|
Disability Evaluation | 13 | 2020 | 1820 | 0.840 |
Why?
|
Immunologic Factors | 6 | 2021 | 1587 | 0.640 |
Why?
|
Neuropsychological Tests | 11 | 2025 | 7123 | 0.630 |
Why?
|
Severity of Illness Index | 20 | 2020 | 15880 | 0.570 |
Why?
|
Computers | 1 | 2018 | 588 | 0.510 |
Why?
|
Mental Health | 5 | 2023 | 3278 | 0.480 |
Why?
|
Social Stigma | 1 | 2020 | 788 | 0.420 |
Why?
|
Atrophy | 13 | 2021 | 1635 | 0.400 |
Why?
|
Disease Progression | 20 | 2024 | 13632 | 0.380 |
Why?
|
Brain | 28 | 2023 | 27171 | 0.370 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 2024 | 564 | 0.330 |
Why?
|
Efficiency | 1 | 2012 | 480 | 0.320 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2001 | 2159 | 0.290 |
Why?
|
Middle Aged | 65 | 2025 | 223009 | 0.290 |
Why?
|
Longitudinal Studies | 21 | 2025 | 14751 | 0.280 |
Why?
|
Adult | 67 | 2025 | 223044 | 0.280 |
Why?
|
Lupus Vasculitis, Central Nervous System | 2 | 2005 | 32 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 34 | 2023 | 36532 | 0.270 |
Why?
|
Female | 75 | 2025 | 396112 | 0.270 |
Why?
|
Depression | 6 | 2020 | 8237 | 0.270 |
Why?
|
Male | 71 | 2025 | 363698 | 0.240 |
Why?
|
Neurofilament Proteins | 3 | 2023 | 337 | 0.240 |
Why?
|
Disabled Persons | 3 | 2018 | 1208 | 0.240 |
Why?
|
Patient Preference | 1 | 2012 | 952 | 0.230 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3475 | 0.220 |
Why?
|
Probiotics | 2 | 2018 | 387 | 0.220 |
Why?
|
Self Report | 2 | 2015 | 3770 | 0.220 |
Why?
|
Humans | 88 | 2025 | 765968 | 0.210 |
Why?
|
Interferon-beta | 2 | 2018 | 346 | 0.200 |
Why?
|
Spouse Abuse | 1 | 2022 | 181 | 0.180 |
Why?
|
Multiple System Atrophy | 1 | 2022 | 132 | 0.180 |
Why?
|
Mental Health Services | 1 | 2012 | 1723 | 0.170 |
Why?
|
Social Support | 3 | 2020 | 2192 | 0.170 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 402 | 0.170 |
Why?
|
Cognition | 7 | 2020 | 7049 | 0.160 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2023 | 363 | 0.160 |
Why?
|
Monocytes | 2 | 2019 | 2595 | 0.160 |
Why?
|
Adaptation, Psychological | 1 | 2009 | 2660 | 0.150 |
Why?
|
Intermediate Filaments | 3 | 2023 | 171 | 0.150 |
Why?
|
Substantia Nigra | 1 | 2020 | 346 | 0.150 |
Why?
|
Neuroglia | 1 | 2024 | 964 | 0.150 |
Why?
|
Functional Laterality | 1 | 2005 | 2243 | 0.150 |
Why?
|
Bifidobacterium | 1 | 2018 | 99 | 0.140 |
Why?
|
Quality of Health Care | 1 | 2012 | 4300 | 0.140 |
Why?
|
Sex Characteristics | 3 | 2023 | 2643 | 0.140 |
Why?
|
Wine | 1 | 2017 | 172 | 0.130 |
Why?
|
Vision Tests | 1 | 2017 | 160 | 0.130 |
Why?
|
Cross-Sectional Studies | 10 | 2025 | 26318 | 0.130 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 291 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 1998 | 183 | 0.130 |
Why?
|
Mental Disorders | 2 | 2013 | 6853 | 0.120 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2015 | 72 | 0.120 |
Why?
|
Lower Extremity | 1 | 2023 | 1226 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2017 | 211 | 0.120 |
Why?
|
Health Services Needs and Demand | 2 | 2013 | 1406 | 0.120 |
Why?
|
Epilepsies, Partial | 1 | 1998 | 431 | 0.110 |
Why?
|
Contraceptives, Oral | 1 | 2017 | 559 | 0.110 |
Why?
|
Electroencephalography | 3 | 2001 | 6273 | 0.110 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 995 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 841 | 0.110 |
Why?
|
Spinal Cord | 2 | 2019 | 1784 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 355 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 329 | 0.100 |
Why?
|
Anxiety | 2 | 2020 | 4671 | 0.100 |
Why?
|
Microglia | 1 | 2020 | 1372 | 0.090 |
Why?
|
Memory, Short-Term | 2 | 2023 | 1003 | 0.090 |
Why?
|
Absenteeism | 1 | 2012 | 246 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 38 | 0.090 |
Why?
|
Lymphocytes | 1 | 2019 | 2599 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 737 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1883 | 0.090 |
Why?
|
Self-Help Groups | 1 | 2012 | 193 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4209 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6547 | 0.090 |
Why?
|
Verbal Behavior | 1 | 2011 | 328 | 0.080 |
Why?
|
Vision Disorders | 1 | 2017 | 1087 | 0.080 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.080 |
Why?
|
Leptin | 1 | 2018 | 1596 | 0.080 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 368 | 0.080 |
Why?
|
Body Mass Index | 3 | 2018 | 13039 | 0.080 |
Why?
|
Employment | 1 | 2015 | 1106 | 0.080 |
Why?
|
Time Factors | 7 | 2019 | 40065 | 0.080 |
Why?
|
HLA Antigens | 2 | 2010 | 1339 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2022 | 2895 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2001 | 1732 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2014 | 1218 | 0.070 |
Why?
|
Androgens | 1 | 2015 | 1279 | 0.070 |
Why?
|
Adiposity | 1 | 2018 | 1890 | 0.070 |
Why?
|
Patient Care | 1 | 2013 | 629 | 0.070 |
Why?
|
Young Adult | 14 | 2021 | 59889 | 0.070 |
Why?
|
Drug Substitution | 1 | 2010 | 292 | 0.070 |
Why?
|
Prognosis | 7 | 2016 | 29922 | 0.070 |
Why?
|
Recurrence | 3 | 2019 | 8501 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2015 | 15398 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6014 | 0.070 |
Why?
|
Limbic System | 2 | 2001 | 418 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1484 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4137 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10850 | 0.070 |
Why?
|
Postmenopause | 1 | 2015 | 2515 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6203 | 0.060 |
Why?
|
Neutrophils | 1 | 2019 | 3776 | 0.060 |
Why?
|
Artifacts | 1 | 2014 | 1893 | 0.060 |
Why?
|
Focus Groups | 1 | 2012 | 1459 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5937 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2011 | 952 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2014 | 3356 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4040 | 0.060 |
Why?
|
Adolescent | 10 | 2021 | 88835 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2007 | 912 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3432 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2023 | 81514 | 0.050 |
Why?
|
Prospective Studies | 11 | 2023 | 54802 | 0.050 |
Why?
|
Health Surveys | 2 | 2013 | 4056 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2011 | 1534 | 0.050 |
Why?
|
Prevalence | 4 | 2022 | 15842 | 0.050 |
Why?
|
Testosterone | 1 | 2014 | 2494 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4405 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3785 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 198 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4034 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9747 | 0.050 |
Why?
|
Organ Size | 2 | 2017 | 2260 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3106 | 0.040 |
Why?
|
Peptides | 2 | 2010 | 4331 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2022 | 312 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2880 | 0.040 |
Why?
|
Iron | 1 | 2009 | 1816 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4908 | 0.040 |
Why?
|
Age of Onset | 3 | 2015 | 3344 | 0.040 |
Why?
|
Epilepsy, Complex Partial | 1 | 1999 | 59 | 0.040 |
Why?
|
Acetanilides | 1 | 2020 | 167 | 0.040 |
Why?
|
Software | 1 | 2013 | 4462 | 0.040 |
Why?
|
Aged | 12 | 2017 | 171117 | 0.040 |
Why?
|
Models, Statistical | 2 | 2010 | 5089 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2012 | 3230 | 0.040 |
Why?
|
Superior Sagittal Sinus | 1 | 2017 | 15 | 0.040 |
Why?
|
Massachusetts | 1 | 2011 | 8875 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2009 | 3714 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 1998 | 616 | 0.030 |
Why?
|
Lactobacillus | 1 | 2018 | 213 | 0.030 |
Why?
|
Health Status | 1 | 2009 | 4080 | 0.030 |
Why?
|
Clinical Competence | 1 | 2012 | 4863 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 772 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 820 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2019 | 621 | 0.030 |
Why?
|
Logistic Models | 3 | 2019 | 13266 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2844 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2010 | 18071 | 0.030 |
Why?
|
Injections | 1 | 2017 | 840 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2012 | 5508 | 0.030 |
Why?
|
Cohort Studies | 5 | 2019 | 41649 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8731 | 0.030 |
Why?
|
Alzheimer Disease | 2 | 2018 | 8730 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1043 | 0.030 |
Why?
|
Gene Frequency | 2 | 2010 | 3624 | 0.030 |
Why?
|
Age Factors | 3 | 2015 | 18380 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2858 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 714 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2001 | 1714 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 814 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14652 | 0.030 |
Why?
|
Prednisone | 1 | 1997 | 1565 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 999 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9081 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1857 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2395 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3211 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.020 |
Why?
|
Alleles | 2 | 2010 | 6897 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4015 | 0.020 |
Why?
|
Pyrroles | 1 | 2015 | 1119 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39193 | 0.020 |
Why?
|
Databases, Factual | 2 | 2019 | 8067 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 608 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2014 | 978 | 0.020 |
Why?
|
Demography | 1 | 2013 | 1641 | 0.020 |
Why?
|
Boston | 1 | 2001 | 9338 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1997 | 1808 | 0.020 |
Why?
|
Radiography | 2 | 2010 | 6919 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 285 | 0.020 |
Why?
|
Visual Acuity | 1 | 2017 | 2708 | 0.020 |
Why?
|
Genotype | 2 | 2010 | 13024 | 0.020 |
Why?
|
New England | 1 | 2009 | 1059 | 0.020 |
Why?
|
Walking | 1 | 2013 | 1198 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 22223 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20124 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.010 |
Why?
|
Image Enhancement | 1 | 2014 | 2858 | 0.010 |
Why?
|
Gadolinium | 1 | 2009 | 965 | 0.010 |
Why?
|
United States | 1 | 2012 | 72903 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2263 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10603 | 0.010 |
Why?
|
Diffusion Tensor Imaging | 1 | 2014 | 2410 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 968 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9525 | 0.010 |
Why?
|
Brain Mapping | 1 | 1998 | 6601 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2652 | 0.010 |
Why?
|
Models, Neurological | 1 | 2010 | 1747 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1998 | 5767 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2009 | 59489 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3449 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11888 | 0.010 |
Why?
|
Animals | 2 | 2022 | 168764 | 0.010 |
Why?
|
Child | 3 | 2015 | 80564 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6499 | 0.010 |
Why?
|
Risk Factors | 3 | 2010 | 74840 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 8923 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2000 | 1978 | 0.010 |
Why?
|
Contrast Media | 1 | 2009 | 5329 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14071 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81819 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65188 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 16047 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12807 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21480 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 1999 | 3270 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_